Geneos Therapeutics

aid: geneos-therapeutics
name: Geneos Therapeutics
description: 'Geneos Therapeutics is a clinical-stage (Phase 2b) biotherapeutics company in Philadelphia, Pennsylvania developing
  DNA-based personalized immunotherapies for cancer (PICs). Its GT-EPIC neoantigen-targeting platform sequences a patient''s
  tumor, identifies the targetable neoantigens, and encodes up to roughly 40 of them into a synthetic DNA plasmid drug product
  delivered intradermally alongside a plasmid-encoded IL-12 adjuvant and CELLECTRA electroporation. Geneos was spun out of
  Inovio Pharmaceuticals and licenses that immunotherapy platform exclusively; it has run clinical work in hepatocellular
  carcinoma (HCC) and glioblastoma (GBM) and is advancing toward a Phase 2b HCC trial. Geneos is a therapeutics developer,
  not a software vendor: it publishes no public API, SDK, developer portal or machine-readable contract of any kind.'
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source:
  - security
  generated: '2026-09-02'
  method: derived
image: https://www.geneostx.com/wp-content/uploads/2021/09/logo-color.svg
url: https://raw.githubusercontent.com/api-evangelist/geneos-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-16'
modified: '2026-08-16'
tags:
- Company
- Biotechnology
- Therapeutics
- Immunotherapy
- Oncology
- Precision Medicine
- Clinical Stage
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.geneostx.com/
- type: PrivacyPolicy
  url: https://www.geneostx.com/privacy-policy/
- type: Support
  url: https://www.geneostx.com/contact/
- type: Blog
  url: https://www.geneostx.com/press-releases/
- type: DomainSecurity
  url: security/geneos-therapeutics-domain-security.yml
- type: LLMsTxt
  url: llms/geneos-therapeutics-llms.txt
x-enrichment:
  date: '2026-08-16'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: Geneos Therapeutics is a Phase 2b clinical-stage cancer-immunotherapy developer whose product is a DNA plasmid drug,
    not software; its six-page WordPress corporate site has no developer, API or technology-integration section at all, api/docs/developer(s)/portal
    subdomains of geneostx.com do not resolve (NXDOMAIN), there is no GitHub organization and no package in npm or PyPI, and
    every contract-discovery and /.well-known/ path probed returned 404.
  evidence:
  - url: https://www.geneostx.com/openapi.json
    status: 404
  - url: https://www.geneostx.com/.well-known/agent-card.json
    status: 404
  - url: https://www.geneostx.com/api
    status: 404
  - url: https://api.github.com/orgs/geneostx
    status: 404
  - url: https://www.geneostx.com/sitemap_index.xml
    status: 200
  checked: '2026-08-16'